A detailed history of Y Intercept (Hong Kong) LTD transactions in Evolus, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 40,908 shares of EOLS stock, worth $443,442. This represents 0.04% of its overall portfolio holdings.

Number of Shares
40,908
Previous 40,813 0.23%
Holding current value
$443,442
Previous $442,000 49.77%
% of portfolio
0.04%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$10.66 - $17.48 $1,012 - $1,660
95 Added 0.23%
40,908 $662,000
Q2 2024

Aug 14, 2024

BUY
$10.45 - $13.76 $235,689 - $310,343
22,554 Added 123.52%
40,813 $442,000
Q1 2024

May 10, 2024

BUY
$9.99 - $14.91 $38,441 - $57,373
3,848 Added 26.7%
18,259 $255,000
Q4 2023

Feb 13, 2024

BUY
$7.6 - $10.53 $109,523 - $151,747
14,411 New
14,411 $151,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.